OpenNashPodcasts

Topic

Albert Bourla

Albert Bourla is the chief executive of Pfizer, and this page collects what he and others said about him on podcasts including Lex Fridman, Freakonomics, M.D., Conversations with Mike Milken and STAT's The Readout Loud. The talks cover Pfizer's COVID vaccine effort, his career and his views on the industry.

Bourla told Lex Fridman that Pfizer committed about $2.3 billion to vaccine development at once instead of in stages. On Freakonomics, M.D., he said the company made its vaccine in nine months, compared with about eight years normally. He also said he was born in Thessaloniki, Greece, and spent about 17 of his nearly 30 years at Pfizer in animal health.

24 facts from 4 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.

2019

Lex Fridman said Albert Bourla had been at Pfizer for 28 years and became CEO in 2019.

“You've been at Pfizer for 28 years. Time flies when you're having fun. And you've become CEO in 2019.”

Lex Fridman · #249 – Albert Bourla: Pfizer CEO, 0:28:54

2020

Albert Bourla said Pfizer committed about $2.3 billion to COVID vaccine development at once instead of in stages.

“Here, we put all together a little bit more than $2 billion, $2.3 billion.”

Albert Bourla · #249 – Albert Bourla: Pfizer CEO, 0:12:46

2021

Albert Bourla said Pfizer's employee vaccination rate rose from 90% to 96% after the company mandated vaccination.

“we were at 90 % vaccination rates when we said we are going to mandate it. And that took it up to 96%.”

Albert Bourla · #249 – Albert Bourla: Pfizer CEO, 1:00:02

2021

Albert Bourla said a false online story claimed his wife had died from vaccination, after an earlier false story claimed he was arrested by the FBI.

“A week later, the wife of the Pfizer CEO died.”

Albert Bourla · #249 – Albert Bourla: Pfizer CEO, 0:51:23

Undated

Bourla says adenovirus-based vaccines are harder to boost because the body also makes antibodies against the adenovirus carrier, which can reduce effectiveness.

“It's not easy to boost with adenovirus because every time you are boosting, you are not creating only antibodies against the coronavirus, but also against the adenovirus, which is the carrier.”

Albert Bourla · 38. Pfizer’s CEO on the Big Gamble That Brought Us the COVID Vaccine, 0:15:20

Undated

Bapu Jena says Bourla told him Pfizer expected to submit data on a three-dose series for children under five, with a third dose appearing to add substantial protection.

“Pfizer expects to submit its data this month on the efficacy of a three-dose series for these kids, and that adding a third dose seemed to provide substantially more protection against COVID compared to just two doses.”

Bapu Jena · 38. Pfizer’s CEO on the Big Gamble That Brought Us the COVID Vaccine, 0:27:14

Episodes